If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
187.50    0.50 (0.27%)
Bid:
185.00
Ask:
190.00
Spread: 5.00 (2.703%)
Market Cap: £97.08m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

19 Jul 2022 07:00

RNS Number : 8731S
Somero Enterprises Inc.
19 July 2022
 

19 July 2022

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

Somero® is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday, 7 September 2022.

Driven by positive momentum from a highly active US non-residential construction market, healthy market conditions and elevated activity levels in the European and Australian markets, Group trading in H1 2022 ended higher than the comparable H1 2021 period. 

 

As expected, H1 2022 trading in North America remained strong, increasing from H1 2021, reflective of customers with sizable workloads and project backlogs that extend well into 2023. The breadth and variety of project activity in the US translated to healthy take rates across the Somero product portfolio including continued, strong performance in the boomed screed category.

 

The European market was active during H1 2022, reflective of positive non-residential construction market conditions and a busy customer base with healthy, extended project backlogs. While H1 2022 trading in Europe was down compared to H1 2021, due largely to logistics challenges that delayed machine shipments, based on the H1 2022 momentum and activity levels alongside anticipated catch-up on shipment delays to start H2 2022, second half 2022 trading is anticipated to accelerate, and Europe is anticipated to contribute to full-year 2022 growth. 

 

H1 2022 trading in Australia was also strong, improving from H1 2021, reflecting similar positive market conditions as the US and Europe, in line with the expectation that the region will contribute meaningfully to 2022 growth. Trading in all other regions also fell in line with expectations, including in China where revenues were down compared to H1 2021 due to the previously announced reduced Company focus on the region and the severe impact of COVID restrictions. 

 

New products, including the SkyScreed®, the S-PS50 Laser Screed® and the Somero Broom+CureTM, contributed meaningfully to H1 2022 sales while the Company continues to make good progress in identifying opportunities to penetrate untapped market segments and with development of new solutions for customers.

 

During the first six months of 2022, the also Company made substantial progress with the Houghton, Michigan building expansion project anticipated to be completed by the end of Q3 2022 and with adding new personnel necessary to support future growth of the business, particularly in our primary US, Europe and Australian markets. 

 

While cognizant of the uncertain macro economic environment, the Board continues to anticipate healthy trading to continue in H2 2022, a view underpinned by direct feedback from customers in the US, Europe & Australian indicating high workloads and extended project backlogs. As such, the Board is pleased to confirm 2022 results are anticipated to fall in line with market expectations for revenues of approximately US$ 138.8m, EBITDA of approximately US$ 47.7m, and year-end cash of approximately US$ 39.9m.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, President

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Kate Bannatyne (Corporate Finance)

Tim Redfern/Richard Chambers (ECM)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

David Ison +44 (0)20 3405 0205

Pippa Crabtree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKFBKABKDAOD
Date   Source Headline
14th Jun 20217:00 amRNSAGM Statement
6th May 20219:05 amRNSSecond Price Monitoring Extn
6th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSTrading Update
22nd Apr 20217:00 amRNSAnnual Report and Notice of AGM
16th Apr 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSTransaction in Own Shares and RSUs
15th Mar 20213:50 pmRNSTransaction in Own Shares and RSUs
11th Mar 20215:00 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFinal Results
5th Mar 20215:00 pmRNSHolding(s) in Company
1st Mar 20212:50 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
15th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Nov 20207:00 amRNSTrading Statement
13th Nov 20204:22 pmRNSHolding(s) in Company
11th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20203:49 pmRNSTransactions in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20209:05 amRNSSecond Price Monitoring Extn
9th Sep 20209:00 amRNSPrice Monitoring Extension
9th Sep 20207:00 amRNSInterim Results
13th Aug 20205:22 pmRNSHolding(s) in Company
4th Aug 20201:53 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading Update
23rd Jun 20201:54 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSResult of AGM
8th Jun 20207:00 amRNSAGM Statement
5th Jun 20207:00 amRNSCOVID-19 Update
26th May 20207:00 amRNSAnnual Report Correction - Replacement
22nd May 20205:30 pmRNSAnnual Report Correction
16th Apr 20207:00 amRNSAnnual Report, AGM Notice & QCA CG Code Adoption
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20209:00 amRNSPrice Monitoring Extension
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.